The availability of the CSIRO's low-cost retinal imaging technology Remote-I for use by GPs to screen for diabetic retinopathy (DR) is one step closer following the successful conclusion of a trial at a GP superclinic in Perth.
CSIRO has been conducting the trial with the GP Superclinic at Midland Railway Workshops in Perth since last November, screening 187 diabetic patients by taking high resolution images and analysing them with CSIRO's Dr Grader software.
The technology has been licensed to US telehealth firm TeleMedC, which plans to make it commercially available and install it in a further 20 practices in WA over the next few months, before expanding across Australia.
